Severe infusion reaction, anti-rituximab antibodies and lymphoma

QJM. 2020 Apr 1;113(4):273-274. doi: 10.1093/qjmed/hcz296.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Antibodies, Monoclonal / adverse effects*
  • Antibodies, Monoclonal, Murine-Derived
  • Antigens, CD20 / immunology
  • Antineoplastic Agents, Immunological / adverse effects*
  • Cytokines / blood
  • Cytokines / immunology
  • Humans
  • Injection Site Reaction / drug therapy
  • Injection Site Reaction / etiology*
  • Lymphoma, Follicular / drug therapy*
  • Lymphoma, Follicular / pathology
  • Male
  • Middle Aged
  • Prednisolone / therapeutic use
  • Rituximab
  • Shock / immunology
  • Shock / physiopathology*
  • Treatment Outcome

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Murine-Derived
  • Antigens, CD20
  • Antineoplastic Agents, Immunological
  • Cytokines
  • Rituximab
  • Prednisolone